Citation: X. Zheng et al., APICALLY SORTED ENTEROPEPTIDASE DOES NOT ASSOCIATE WITH DETERGENT-RESISTANT SPHINGOLIPID-CHOLESTEROL RAFTS, Molecular biology of the cell, 9, 1998, pp. 2641-2641
Authors:
YUAN X
ZHENG XL
LU DS
RUBIN DC
PUNG CYM
SADLER JE
Citation: X. Yuan et al., STRUCTURE OF MURINE ENTEROKINASE (ENTEROPEPTIDASE) AND EXPRESSION IN SMALL-INTESTINE DURING DEVELOPMENT, American journal of physiology: Gastrointestinal and liver physiology, 37(2), 1998, pp. 342-349
Authors:
XUE JC
WU QY
WESTFIELD LA
TULEY EA
LU DS
ZHANG Q
SHIM K
ZHENG XL
SADLER JE
Citation: Jc. Xue et al., INCOMPLETE EMBRYONIC LETHALITY AND FATAL NEONATAL HEMORRHAGE CAUSED BY PROTHROMBIN DEFICIENCY IN MICE, Proceedings of the National Academy of Sciences of the United Statesof America, 95(13), 1998, pp. 7603-7607
Authors:
WU QY
YU DY
POST J
HALKSMILLER M
SADLER JE
MORSER J
Citation: Qy. Wu et al., GENERATION AND CHARACTERIZATION OF MICE DEFICIENT IN HEPSIN, A HEPATIC TRANSMEMBRANE SERINE-PROTEASE, The Journal of clinical investigation, 101(2), 1998, pp. 321-326
Citation: K. Kokame et al., ACTIVATION OF THROMBIN-ACTIVABLE FIBRINOLYSIS INHIBITOR REQUIRES EPIDERMAL GROWTH FACTOR-LIKE DOMAIN-3 OF THROMBOMODULIN AND IS INHIBITED COMPETITIVELY BY PROTEIN-C, The Journal of biological chemistry, 273(20), 1998, pp. 12135-12139
Authors:
HILLERY CA
MANCUSO DJ
SADLER JE
PONDER JW
JOZWIAK MA
CHRISTOPHERSON PA
GILL JC
SCOTT JP
MONTGOMERY RR
Citation: Ca. Hillery et al., TYPE 2M VON-WILLEBRAND-DISEASE - F606I AND I662F MUTATIONS IN THE GLYCOPROTEIN IB BINDING DOMAIN SELECTIVELY IMPAIR RISTOCETIN - BUT NOT BOTROCETIN-MEDIATED BINDING OF VON-WILLEBRAND-FACTOR TO PLATELETS, Blood, 91(5), 1998, pp. 1572-1581
Authors:
XUE J
WU Q
WESTFIELD LA
TULEY EA
LU D
ZHANG Q
ZHENG X
SADLER JE
Citation: J. Xue et al., PARTIAL EMBRYONIC LETHALITY INDUCED BY TARGETED INACTIVATION OF THE PROTHROMBIN GENE IN MICE, Thrombosis and haemostasis, 1997, pp. 707-707
Citation: T. Matsushita et Je. Sadler, CHARACTERIZATION OF LIGAND-BINDING TO HUMAN VON-WILLEBRAND-FACTOR DOMAIN A1 BY SINGLE RESIDUE CHARGED-TO-ALANINE SCANNING MUTAGENESIS, Thrombosis and haemostasis, 1997, pp. 1489-1489
Citation: Qy. Wu et al., GENERATION AND CHARACTERIZATION OF MICE DEFICIENT FOR THE SERINE-PROTEASE HEPSIN, Thrombosis and haemostasis, 1997, pp. 3090-3090
Citation: Je. Sadler, COMBINED FACTOR-V AND FACTOR-VIII DEFICIENCY CLIMBS ONTO THE MAP, The Journal of clinical investigation, 99(4), 1997, pp. 555-556
Citation: Ds. Lu et al., BOVINE PROENTEROPEPTIDASE IS ACTIVATED BY TRYPSIN, AND THE SPECIFICITY OF ENTEROPEPTIDASE DEPENDS ON THE HEAVY-CHAIN, The Journal of biological chemistry, 272(50), 1997, pp. 31293-31300
Authors:
LI CQ
VINDIGNI A
DICERA E
SADLER JE
WARDELL MR
Citation: Cq. Li et al., THROMBIN BINDING TO PLATELET GLYCOPROTEIN IB-IX IS MEDIATED BY ITS ANION-BINDING EXOSITE-II AND IS LARGELY ELECTROSTATIC IN NATURE, Blood, 90(10), 1997, pp. 1911-1911
Authors:
EIKENBOOM JCJ
MATSUSHITA T
REITSMA PH
TULEY EA
CASTAMAN G
BRIET E
SADLER JE
Citation: Jcj. Eikenboom et al., DOMINANT TYPE-1 VON-WILLEBRAND DISEASE CAUSED BY MUTATED CYSTEINE RESIDUES IN THE D3 DOMAIN OF VON-WILLEBRAND-FACTOR, Blood, 88(7), 1996, pp. 2433-2441
Authors:
ENGLENDER T
LATTUADA A
MANNUCCI PM
SADLER JE
INBAL A
Citation: T. Englender et al., ANALYSIS OF ARG834GLN AND VA1902GLU TYPE 2A VON-WILLEBRAND DISEASE MUTATIONS - STUDIES WITH RECOMBINANT VON-WILLEBRAND-FACTOR AND CORRELATION WITH PATIENT CHARACTERISTICS, Blood, 87(7), 1996, pp. 2788-2794
Authors:
DEBOSCH NB
TULEY EA
TORRES A
SAEZ A
SADLER JE
Citation: Nb. Debosch et al., A NEW FAMILY WITH TYPE 2N (NORMANDY) VON-WILLEBRAND DISEASE WITH THE ARG53-]TRP MUTATION, Thrombosis and haemostasis, 73(6), 1995, pp. 1167-1167
Authors:
EIKENBOOM JCJ
REITSMA PH
CASTAMAN G
TULEY EA
BRIET E
SADLER JE
Citation: Jcj. Eikenboom et al., DOMINANT TYPE-1 VON-WILLEBRAND DISEASE-ASSOCIATED WITH MUTATED CYSTEINE RESIDUES IN THE D3-DOMAIN OF VON-WILLEBRAND-FACTOR, Thrombosis and haemostasis, 73(6), 1995, pp. 1170-1170
Citation: A. Inbal et al., VERY-LOW FREQUENCY OF NORMANDY TYPE MUTATIONS AMONG TYPE-1 VON-WILLEBRAND DISEASE FAMILIES, Thrombosis and haemostasis, 73(2), 1995, pp. 324-324